Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.717 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Sara Rahavi-Ezabadi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Otorhinolaryngology Research Center, Children's Medical Center, Tehran University of Medical…. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Biological Therapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Objective
Provide clinicians with current evidence for biologic therapy in children with chronic rhinosinusitis with nasal polyposis (CRSwNP). Data Sources PubMed, MEDLINE, Cochrane, and clinical trial registries. Review Methods Key search terms related to biologic therapy in pediatric CRSwNP were identified via a structured query of current medical literature and clinical trial databases.
Conclusions
There is a dearth of active clinical trials and research studies for biologics targeting pediatric CRSwNP. There is an ongoing compassionate‐use clinical trial involving Dupilumab for children with nasal polyps as well as only 1 published work specifically focused on Dupilumab for pediatric CRSwNP in the setting of aspirin‐exacerbated respiratory disease.
Implications for Practice
For children with atopic dermatitis, asthma, and chronic idiopathic urticaria, biologic therapies such as Omalizumab, Dupilumab, and Mepolizumab have gained Food and Drug Administration approval. The role of biologic therapy in pediatric CRSwNP demonstrates significant promise in the comprehensive management of the unified airway. Additional Phase III trials are necessary to broaden clinical indications for children with comorbid conditions and complex sinonasal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Otorhinolaryngology Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
- USC Caruso Department of Otolaryngology-Head and Neck Surgery, Los Angeles, California, USA.
- Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Otolaryngology, Facey Medical Group, Los Angeles, California, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of California San Diego, La Jolla, California, USA.
- Division of Pediatric Otolaryngology, Rady Children's Hospital-San Diego, San Diego, California, USA.
ORCID-Profile: Sara Rahavi-Ezabadi, Vijay A Patel
Zitieren
APA
Rahavi-Ezabadi, S., Zhou, S., Lee, S. E., Ference, E., Magit, A., Leuin, S., Mohamed, K., Rezaei, N., & Patel, V. A. (2024). Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.717
Vancouver
Rahavi-Ezabadi S, Zhou S, Lee SE, Ference E, Magit A, Leuin S, et al. Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.717
BibTeX
@article{RahaviEzabadi2024,
author = {Rahavi-Ezabadi, Sara and Zhou, Sheng and Lee, Stella E and Ference, Elisabeth and Magit, Anthony and Leuin, Shelby and Mohamed, Kawthar and Rezaei, Nima and Patel, Vijay A},
title = {Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.717}
}
EUVIMED